close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

A

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

8.64 1.05

Strong Buy

Prijsupdate 16 apr 2026, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.37

Max

8.92

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+75.23% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

30M

187M

Vorige openingsprijs

7.59

Vorige sluitingsprijs

8.64

Nieuwssentiment

By Acuity

50%

50%

167 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 apr 2026, 23:14 UTC

Winsten

Battery Maker CATL First-Quarter Net Rose on Strong Demand

DJ

Lezen

15 apr 2026, 23:14 UTC

Winsten

Battery Maker CATL First Quarter Net Rose On Strong Demand

DJ

Lezen

15 apr 2026, 17:13 UTC

Belangrijke Marktbewegers

Tesla Shares Rise on Completion of AI5 Chip Design Process

DJ

Lezen

15 apr 2026, 23:39 UTC

Marktinformatie

Nikkei May Rise After Gains on Wall Street -- Market Talk

DJ

Lezen

15 apr 2026, 23:35 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

DJ

Lezen

15 apr 2026, 22:41 UTC

Winsten

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

DJ

Lezen

15 apr 2026, 22:38 UTC

Winsten

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

DJ

Lezen

15 apr 2026, 22:15 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

15 apr 2026, 22:15 UTC

Marktinformatie

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

DJ

Lezen

15 apr 2026, 22:14 UTC

Winsten

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

DJ

Lezen

15 apr 2026, 22:12 UTC

Winsten

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

DJ

Lezen

15 apr 2026, 22:11 UTC

Winsten

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

DJ

Lezen

15 apr 2026, 22:11 UTC

Winsten

Lens Technology Swings to Loss in 1Q>300433.SZ

DJ

Lezen

15 apr 2026, 22:07 UTC

Winsten

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

DJ

Lezen

15 apr 2026, 21:34 UTC

Acquisities, Fusies, Overnames

Skild AI Acquires Zebra Technologies' Robotics Automation Business

DJ

Lezen

15 apr 2026, 21:29 UTC

Populaire aandelen

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

DJ

Lezen

15 apr 2026, 20:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

DJ

Lezen

15 apr 2026, 20:30 UTC

Winsten

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

DJ

Lezen

15 apr 2026, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

15 apr 2026, 20:06 UTC

Marktinformatie

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

DJ

Lezen

15 apr 2026, 19:46 UTC

Winsten
Acquisities, Fusies, Overnames

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

DJ

Lezen

15 apr 2026, 19:25 UTC

Marktinformatie

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

DJ

Lezen

15 apr 2026, 19:00 UTC

Marktinformatie

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

DJ

Lezen

15 apr 2026, 18:58 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

DJ

Lezen

15 apr 2026, 18:11 UTC

Acquisities, Fusies, Overnames

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

DJ

Lezen

15 apr 2026, 17:45 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

DJ

Lezen

15 apr 2026, 16:58 UTC

Winsten

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

DJ

Lezen

15 apr 2026, 16:52 UTC

Winsten

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

DJ

Lezen

15 apr 2026, 16:46 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

DJ

Lezen

15 apr 2026, 16:37 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

75.23% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15 USD  75.23%

Hoogste 28 USD

Laagste 8 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

167 / 348 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

85.6

↓-1.76%

A

Agilent Technologies Inc

118.07

↓-1.12%

VEEV

Veeva Systems Inc

167.35

↓-0.11%

HQY

HealthEquity Inc

84.4

↑ +0.63%

NEOG

Neogen Corp

9.24

↓-2.01%
help-icon Live chat